Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource‐rich developing country

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|6|945-950

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 945-950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2140-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neuropsychological functioning of children treated for acute lymphoblastic leukemia: impact of whole brain radiation therapy

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 2, 2015-02 ,pp. : 181-189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal Fluid Excitatory Amino Acids and Tau Protein in Children with Acute Lymphoblastic Leukemia Treated according to the BFM Protocol

By  

Acta Haematologica, Vol. 112, Iss. 4, 2004-11 ,pp. : 222-224

Karger

Access to resources Recommend Favorite

Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite